Together, these results suggest that QSOX1 is associated with intrinsic gefitinib resistance in NSCLC cells and the NSUN2-YBX1-QSOX1 axis plays crucial roles in intrinsic resistance to EGFR-TKIs in NSCLC. Here, YBX1 is linked to non-small cell lung carcinoma.